News InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate – INM-755 – for its Epidermolysis Bullosa Program April 30, 2019Add Commentby Shared Content
News Alternate Health announces latest innovation in cannabis tech April 30, 2019Add Commentby Shared Content
News CannAmerica Signs LOI to Build CBD Facility in Mexico April 29, 2019Add Commentby Shared Content